{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T16:43:04Z","timestamp":1751906584267},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00059-022-05132-8","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T20:02:47Z","timestamp":1660334567000},"page":"442-448","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diabetes, heart failure, and myocardial revascularization: Is there a new message from the ISCHEMIA trial?"],"prefix":"10.1007","volume":"47","author":[{"given":"Franz-Josef","family":"Neumann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"issue":"9733","key":"5132_CR1","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar\u00a0N, Gao\u00a0P, Seshasai\u00a0SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a\u00a0collaborative meta-analysis of 102 prospective studies. Lancet 375(9733):2215\u20132222","journal-title":"Lancet"},{"issue":"2","key":"5132_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0735-1097(00)00732-4","volume":"36","author":"T Hammoud","year":"2000","unstructured":"Hammoud\u00a0T, Tanguay\u00a0JF, Bourassa\u00a0MG (2000) Management of coronary artery disease: therapeutic options in patients with diabetes. J\u00a0Am Coll Cardiol 36(2):355\u2013365","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"5132_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0895-4356(01)00359-6","volume":"54","author":"HE Resnick","year":"2001","unstructured":"Resnick\u00a0HE, Shorr\u00a0RI, Kuller\u00a0L et al (2001) Prevalence and clinical implications of American Diabetes Association-defined diabetes and other categories of glucose dysregulation in older adults: the health, aging and body composition study. J\u00a0Clin Epidemiol 54(9):869\u2013876","journal-title":"J Clin Epidemiol"},{"issue":"19","key":"5132_CR4","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","volume":"287","author":"JA Beckman","year":"2002","unstructured":"Beckman\u00a0JA, Creager\u00a0MA, Libby\u00a0P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287(19):2570\u20132581","journal-title":"JAMA"},{"issue":"6","key":"5132_CR5","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/S0735-1097(01)01183-4","volume":"37","author":"F Ledru","year":"2001","unstructured":"Ledru\u00a0F, Ducimeti\u00e8re\u00a0P, Battaglia\u00a0S et\u00a0al (2001) New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. J\u00a0Am Coll Cardiol 37(6):1543\u20131550","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"5132_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jacc.2003.08.050","volume":"43","author":"A Norhammar","year":"2004","unstructured":"Norhammar\u00a0A, Malmberg\u00a0K, Diderholm\u00a0E et\u00a0al (2004) Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J\u00a0Am Coll Cardiol 43(4):585\u2013591","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"5132_CR7","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1016\/j.jacc.2009.12.053","volume":"55","author":"A Mente","year":"2010","unstructured":"Mente\u00a0A, Yusuf\u00a0S, Islam\u00a0S et al (2010) Metabolic syndrome and risk of acute myocardial infarction a\u00a0case-control study of 26,903 subjects from 52\u00a0countries. J\u00a0Am Coll Cardiol 55(21):2390\u20132398","journal-title":"J Am Coll Cardiol"},{"issue":"3 Suppl","key":"5132_CR8","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.jcmg.2012.01.008","volume":"5","author":"SP Marso","year":"2012","unstructured":"Marso\u00a0SP, Mercado\u00a0N, Maehara\u00a0A et\u00a0al (2012) Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes. JACC Cardiovasc Imaging 5(3 Suppl):S42\u2013S52","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"5132_CR9","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1161\/01.CIR.92.7.1731","volume":"92","author":"JA Silva","year":"1995","unstructured":"Silva\u00a0JA, Escobar\u00a0A, Collins\u00a0TJ et\u00a0al (1995) Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients. Circulation 92(7):1731\u20131736","journal-title":"Circulation"},{"key":"5132_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/dmr.5610080106","volume":"8","author":"H Ishii","year":"1992","unstructured":"Ishii\u00a0H, Umeda\u00a0F, Nawata\u00a0H (1992) Platelet function in diabetes mellitus. Diabetes Metab Rev 8:53\u201366","journal-title":"Diabetes Metab Rev"},{"key":"5132_CR11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/BF00401055","volume":"36","author":"A Ceriello","year":"1993","unstructured":"Ceriello\u00a0A (1993) Coagulation activation in diabetes mellitus: a\u00a0role of hyperglycemia and therapeutic prospects. Diabetologia 36:1119\u20131125","journal-title":"Diabetologia"},{"issue":"4","key":"5132_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner\u00a0SM, Lehto\u00a0S, R\u00f6nnemaa\u00a0T et\u00a0al (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N\u00a0Engl J Med 339(4):229\u2013234","journal-title":"N Engl J Med"},{"key":"5132_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/0002-9149(94)90399-9","volume":"74","author":"JI Barzilay","year":"1994","unstructured":"Barzilay\u00a0JI, Kronmal\u00a0RA, Bittner\u00a0V et\u00a0al (1994) Coronary artery disease and coronary artery bypass grafting in diabetic patients aged \u3009 or = 65\u00a0years (report from the Coronary Artery Surgery Study [CASS]Registry). Am J Cardiol 74:334\u2013339","journal-title":"Am J Cardiol"},{"issue":"23","key":"5132_CR14","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.ehj.2004.07.041","volume":"25","author":"AJ Scheen","year":"2004","unstructured":"Scheen\u00a0AJ, Warzee\u00a0F, Legrand\u00a0VM (2004) Drug-eluting stents: meta-analysis in diabetic patients. Eur Heart\u00a0J 25(23):2167\u20132168 (author reply 2168\u20139)","journal-title":"Eur Heart J"},{"key":"5132_CR15","doi-asserted-by":"publisher","first-page":"e5170","DOI":"10.1136\/bmj.e5170","volume":"345","author":"S Bangalore","year":"2012","unstructured":"Bangalore\u00a0S, Kumar\u00a0S, Fusaro\u00a0M et al (2012) Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844\u00a0patient years of follow-up from randomised trials. BMJ 345:e5170","journal-title":"BMJ"},{"issue":"9","key":"5132_CR16","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1161\/01.CIR.103.9.1218","volume":"103","author":"E Van Belle","year":"2001","unstructured":"Van Belle\u00a0E, Ketelers\u00a0R, Bauters\u00a0C et al (2001) Patency of percutaneous transluminal coronary angioplasty sites at 6\u2011month angiographic follow-up: a key determinant of survival in diabetics after coronary balloon angioplasty. Circulation 103(9):1218\u20131224","journal-title":"Circulation"},{"issue":"2","key":"5132_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann\u00a0FJ, Sousa-Uva\u00a0M, Ahlsson\u00a0A et al (2019) 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart\u00a0J 40(2):87\u2013165","journal-title":"Eur Heart J"},{"issue":"14","key":"5132_CR18","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet\u00a0JP, Thiele\u00a0H, Barbato\u00a0E et al (2021) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart\u00a0J 42(14):1289\u20131367","journal-title":"Eur Heart J"},{"issue":"3","key":"5132_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti\u00a0J, Wijns\u00a0W, Saraste\u00a0A et\u00a0al (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart\u00a0J 41(3):407\u2013477","journal-title":"Eur Heart J"},{"key":"5132_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","volume":"361","author":"EC Keeley","year":"2003","unstructured":"Keeley\u00a0EC, Boura\u00a0JA, Grines\u00a0CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a\u00a0quantitative review of 23 randomised trials. Lancet 361:13\u201320","journal-title":"Lancet"},{"issue":"16","key":"5132_CR21","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","volume":"374","author":"EJ Velazquez","year":"2016","unstructured":"Velazquez\u00a0EJ, Lee\u00a0KL, Jones\u00a0RH et al (2016) Coronary-artery bypass surgery in patients with Ischemic cardiomyopathy. N\u00a0Engl J Med 374(16):1511\u20131520","journal-title":"N Engl J Med"},{"issue":"22","key":"5132_CR22","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.115.021168","volume":"133","author":"S Bangalore","year":"2016","unstructured":"Bangalore\u00a0S, Guo\u00a0Y, Samadashvili\u00a0Z et al (2016) Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction: everolimus-eluting stents versus coronary artery bypass graft surgery. Circulation 133(22):2132\u20132140","journal-title":"Circulation"},{"issue":"8","key":"5132_CR23","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/eurheartj\/ehq500","volume":"32","author":"R Hachamovitch","year":"2011","unstructured":"Hachamovitch\u00a0R, Rozanski\u00a0A, Shaw\u00a0LJ et al (2011) Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart\u00a0J 32(8):1012\u20131024","journal-title":"Eur Heart J"},{"issue":"10","key":"5132_CR24","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.107.743963","volume":"117","author":"LJ Shaw","year":"2008","unstructured":"Shaw\u00a0LJ, Berman\u00a0DS, Maron\u00a0DJ et\u00a0al (2008) Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117(10):1283\u20131291","journal-title":"Circulation"},{"issue":"8922","key":"5132_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(94)91963-1","volume":"344","author":"S Yusuf","year":"1994","unstructured":"Yusuf\u00a0S, Zucker\u00a0D, Peduzzi\u00a0P et al (1994) Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344(8922):563\u2013570","journal-title":"Lancet"},{"issue":"13","key":"5132_CR26","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1161\/01.CIR.0000089189.70578.E2","volume":"108","author":"TF L\u00fcscher","year":"2003","unstructured":"L\u00fcscher\u00a0TF, Creager\u00a0MA, Beckman\u00a0JA, Cosentino\u00a0F (2003) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation 108(13):1655\u20131661","journal-title":"Circulation"},{"issue":"6","key":"5132_CR27","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.ahj.2013.09.008","volume":"166","author":"S Bangalore","year":"2013","unstructured":"Bangalore\u00a0S, Pencina\u00a0MJ, Kleiman\u00a0NS, Cohen\u00a0DJ (2013) Prognostic implications of procedural vs spontaneous myocardial infarction: results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. Am Heart\u00a0J 166(6):1027\u20131034","journal-title":"Am Heart J"},{"issue":"4","key":"5132_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1161\/CIRCULATIONAHA.111.061663","volume":"125","author":"P Damman","year":"2012","unstructured":"Damman\u00a0P, Wallentin\u00a0L, Fox\u00a0KA et al (2012) Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a\u00a0collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA\u20113 trials (FIR). Circulation 125(4):568\u2013576","journal-title":"Circulation"},{"issue":"22","key":"5132_CR29","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.jacc.2010.03.007","volume":"55","author":"KA Fox","year":"2010","unstructured":"Fox\u00a0KA, Clayton\u00a0TC, Damman\u00a0P et al (2010) Long-term outcome of a\u00a0routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a\u00a0meta-analysis of individual patient data. J\u00a0Am Coll Cardiol 55(22):2435\u20132445","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"5132_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jacc.2012.02.059","volume":"60","author":"ML O\u2019Donoghue","year":"2012","unstructured":"O\u2019Donoghue\u00a0ML, Vaidya\u00a0A, Afsal\u00a0R et al (2012) An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a\u00a0collaborative meta-analysis of randomized trials. J\u00a0Am Coll Cardiol 60(2):106\u2013111","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"5132_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/eurheartj\/ehy812","volume":"40","author":"FM Zimmermann","year":"2019","unstructured":"Zimmermann\u00a0FM, Omerovic\u00a0E, Fournier\u00a0S et al (2019) Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data. Eur Heart\u00a0J 40(2):180\u2013186","journal-title":"Eur Heart J"},{"issue":"16","key":"5132_CR32","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.jacc.2014.07.973","volume":"64","author":"NP Johnson","year":"2014","unstructured":"Johnson\u00a0NP, T\u00f3th\u00a0GG, Lai\u00a0D et\u00a0al (2014) Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J\u00a0Am Coll Cardiol 64(16):1641\u20131654","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"5132_CR33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.117.031907","volume":"137","author":"WF Fearon","year":"2018","unstructured":"Fearon\u00a0WF, Nishi\u00a0T, De Bruyne\u00a0B et al (2018) Clinical outcomes and cost-effectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: three-year follow-up of the FAME 2 trial (fractional flow reserve versus Angiography for Multivessel evaluation). Circulation 137(5):480\u2013487","journal-title":"Circulation"},{"issue":"25","key":"5132_CR34","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1016\/j.jacc.2017.10.036","volume":"70","author":"SJ Baron","year":"2017","unstructured":"Baron\u00a0SJ, Chinnakondepalli\u00a0K, Magnuson\u00a0EA et al (2017) Quality-of-life after everolimus-eluting stents or bypass surgery for left-main disease: results from the EXCEL trial. J\u00a0Am Coll Cardiol 70(25):3113\u20133122","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"5132_CR35","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.jacc.2017.02.031","volume":"69","author":"MS Abdallah","year":"2017","unstructured":"Abdallah\u00a0MS, Wang\u00a0K, Magnuson\u00a0EA et al (2017) Quality of life after surgery or DES in patients with 3\u2011vessel or left main disease. J\u00a0Am Coll Cardiol 69(16):2039\u20132050","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"5132_CR36","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1001\/jama.2013.279208","volume":"310","author":"MS Abdallah","year":"2013","unstructured":"Abdallah\u00a0MS, Wang\u00a0K, Magnuson\u00a0EA et\u00a0al (2013) Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a\u00a0randomized clinical trial. JAMA 310(15):1581\u20131590","journal-title":"JAMA"},{"issue":"15","key":"5132_CR37","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","volume":"382","author":"DJ Maron","year":"2020","unstructured":"Maron\u00a0DJ, Hochman\u00a0JS, Reynolds\u00a0HR et\u00a0al (2020) Initial invasive or conservative strategy for stable coronary disease. N\u00a0Engl J Med 382(15):1395\u20131407","journal-title":"N Engl J Med"},{"issue":"17","key":"5132_CR38","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","volume":"382","author":"S Bangalore","year":"2020","unstructured":"Bangalore\u00a0S, Maron\u00a0DJ, O\u2019Brien\u00a0SM et\u00a0al (2020) Management of coronary disease in patients with advanced kidney disease. N\u00a0Engl J Med 382(17):1608\u20131618","journal-title":"N Engl J Med"},{"issue":"8","key":"5132_CR39","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.120.047987","volume":"143","author":"BR Chaitman","year":"2021","unstructured":"Chaitman\u00a0BR, Alexander\u00a0KP, Cyr\u00a0DD et\u00a0al (2021) Myocardial infarction in the ISCHEMIA trial: impact of different definitions on incidence, prognosis, and treatment comparisons. Circulation 143(8):790\u2013804","journal-title":"Circulation"},{"issue":"15","key":"5132_CR40","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","volume":"382","author":"JA Spertus","year":"2020","unstructured":"Spertus\u00a0JA, Jones\u00a0PG, Maron\u00a0DJ et al (2020) Health-status outcomes with invasive or conservative care in coronary disease. N\u00a0Engl J Med 382(15):1408\u20131419","journal-title":"N Engl J Med"},{"issue":"13","key":"5132_CR41","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/CIRCULATIONAHA.120.049755","volume":"144","author":"HR Reynolds","year":"2021","unstructured":"Reynolds\u00a0HR, Shaw\u00a0LJ, Min\u00a0JK et\u00a0al (2021) Outcomes in the ISCHEMIA trial based on coronary artery disease and Ischemia severity. Circulation 144(13):1024\u20131038","journal-title":"Circulation"},{"issue":"18","key":"5132_CR42","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.120.050304","volume":"142","author":"RD Lopes","year":"2020","unstructured":"Lopes\u00a0RD, Alexander\u00a0KP, Stevens\u00a0SR et\u00a0al (2020) Initial invasive versus conservative management of stable Ischemic heart disease in patients with a\u00a0history of heart failure or left ventricular dysfunction: insights from the ISCHEMIA trial. Circulation 142(18):1725\u20131735","journal-title":"Circulation"},{"issue":"17","key":"5132_CR43","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1161\/CIRCULATIONAHA.121.054439","volume":"144","author":"JD Newman","year":"2021","unstructured":"Newman\u00a0JD, Anthopolos\u00a0R, Mancini\u00a0GBJ et\u00a0al (2021) Outcomes of participants with diabetes in the ISCHEMIA trials. Circulation 144(17):1380\u20131395","journal-title":"Circulation"},{"issue":"25","key":"5132_CR44","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","volume":"367","author":"ME Farkouh","year":"2012","unstructured":"Farkouh\u00a0ME, Domanski\u00a0M, Sleeper\u00a0LA et\u00a0al (2012) Strategies for multivessel revascularization in patients with diabetes. N\u00a0Engl J Med 367(25):2375\u20132384","journal-title":"N Engl J Med"},{"issue":"10124","key":"5132_CR45","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","volume":"391","author":"SJ Head","year":"2018","unstructured":"Head\u00a0SJ, Milojevic\u00a0M, Daemen\u00a0J et\u00a0al (2018) Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a\u00a0pooled analysis of individual patient data. Lancet 391(10124):939\u2013948","journal-title":"Lancet"},{"key":"5132_CR46","doi-asserted-by":"crossref","unstructured":"BARI I. Influence of diabetes on 5\u2011year mortality and morbidity in a\u00a0randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997;96:1761\u20139.","DOI":"10.1161\/01.CIR.96.6.1761"},{"issue":"5","key":"5132_CR47","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/ejcts\/ezt017","volume":"43","author":"AP Kappetein","year":"2013","unstructured":"Kappetein\u00a0AP, Head\u00a0SJ, Morice\u00a0MC et al (2013) Treatment of complex coronary artery disease in patients with diabetes: 5\u2011year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg 43(5):1006\u20131013","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"5132_CR48","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jacc.2009.10.014","volume":"55","author":"A Kapur","year":"2010","unstructured":"Kapur\u00a0A, Hall\u00a0RJ, Malik\u00a0IS et al (2010) Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1\u2011year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J\u00a0Am Coll Cardiol 55(5):432\u2013440","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"5132_CR49","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.jacc.2019.01.037","volume":"73","author":"M Milojevic","year":"2019","unstructured":"Milojevic\u00a0M, Serruys\u00a0PW, Sabik\u00a0JF 3rd et\u00a0al (2019) Bypass surgery or stenting for left main coronary artery disease in patients with diabetes. J\u00a0Am Coll Cardiol 73(13):1616\u20131628","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"5132_CR50","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1056\/NEJMoa1909406","volume":"381","author":"GW Stone","year":"2019","unstructured":"Stone\u00a0GW, Kappetein\u00a0AP, Sabik\u00a0JF et al (2019) Five-year outcomes after PCI or CABG for left main coronary disease. N\u00a0Engl J Med 381(19):1820\u20131830","journal-title":"N Engl J Med"},{"issue":"3","key":"5132_CR51","first-page":"e4","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton\u00a0JS, Tamis-Holland\u00a0JE, Bangalore\u00a0S et al (2022) 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 145(3):e4\u2013e17","journal-title":"Circulation"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-022-05132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-022-05132-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-022-05132-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T15:05:43Z","timestamp":1664550343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-022-05132-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["5132"],"URL":"https:\/\/doi.org\/10.1007\/s00059-022-05132-8","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"15 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"F.-J.\u00a0Neumann reports speaker fees from Amgen, Boston Scientific, and Daiichi Sankyo and consulting fees from Novartis as well as speaker fees to his institution from Bayer Healthcare, Biotronic, Boehringer Ingelheim, Edwards Lifesciences, Ferrer, and Pfizer; consulting fees to his institution from Boehringer Ingelheim; financial study support from Bayer Healthcare, Boston Scientific, Biotronic, Edwards Lifesciences, GlaxoSmithKline, Medtronic, and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}